Addus HomeCare (NASDAQ:ADUS) Price Target Increased to $118.00 by Analysts at Bank of America

Addus HomeCare (NASDAQ:ADUS) had its price objective boosted by Bank of America from $115.00 to $118.00 in a report released on Tuesday morning, Benzinga reports. The brokerage currently has a buy rating on the stock.

A number of other brokerages also recently commented on ADUS. William Blair reiterated an outperform rating on shares of Addus HomeCare in a research note on Monday, February 5th. Oppenheimer reaffirmed an outperform rating and set a $118.00 price objective on shares of Addus HomeCare in a research report on Tuesday, March 26th. Barclays lowered Addus HomeCare from an equal weight rating to an underweight rating and set a $83.00 target price on the stock. in a research report on Tuesday, April 23rd. Finally, Royal Bank of Canada reaffirmed an outperform rating and issued a $102.00 price target on shares of Addus HomeCare in a report on Thursday, February 29th. One equities research analyst has rated the stock with a sell rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of Moderate Buy and a consensus price target of $106.57.

Addus HomeCare Trading Up 6.8 %

NASDAQ:ADUS opened at $104.59 on Tuesday. The stock has a fifty day moving average price of $98.73 and a 200 day moving average price of $92.61. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.18. Addus HomeCare has a 12-month low of $78.35 and a 12-month high of $105.53. The firm has a market cap of $1.71 billion, a PE ratio of 27.24, a price-to-earnings-growth ratio of 1.94 and a beta of 0.96.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, May 6th. The company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $0.97 by $0.24. Addus HomeCare had a return on equity of 9.70% and a net margin of 5.91%. The business had revenue of $280.70 million during the quarter, compared to the consensus estimate of $279.49 million. During the same period in the previous year, the company posted $0.84 earnings per share. The business’s revenue for the quarter was up 11.6% on a year-over-year basis. Sell-side analysts anticipate that Addus HomeCare will post 4.38 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Addus HomeCare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ADUS. Principal Securities Inc. purchased a new position in shares of Addus HomeCare during the fourth quarter worth approximately $26,000. BluePath Capital Management LLC acquired a new position in Addus HomeCare in the third quarter valued at $31,000. GAMMA Investing LLC purchased a new stake in shares of Addus HomeCare in the fourth quarter valued at about $34,000. Assetmark Inc. boosted its stake in shares of Addus HomeCare by 17.1% during the third quarter. Assetmark Inc. now owns 1,331 shares of the company’s stock worth $113,000 after buying an additional 194 shares during the period. Finally, DekaBank Deutsche Girozentrale acquired a new position in Addus HomeCare in the 3rd quarter valued at about $189,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.